End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
149.6 USD | +1.39% |
|
+1.78% | -4.98% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- JNJ Stock
- JNJ_KZ Stock
- Revisions Johnson & Johnson